{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:12:44Z","timestamp":1779343964430,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113141"],"award-info":[{"award-number":["R01NS113141"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.scr.2021.102323","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T21:59:12Z","timestamp":1617659952000},"page":"102323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease"],"prefix":"10.1016","volume":"53","author":[{"given":"Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana M.","family":"Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.scr.2021.102323_b0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation","volume":"59","author":"Anna","year":"2018","journal-title":"J. Appl. Genet."},{"issue":"2","key":"10.1016\/j.scr.2021.102323_b0010","doi-asserted-by":"crossref","first-page":"e17118","DOI":"10.1371\/journal.pone.0017118","article-title":"Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells","volume":"6","author":"Cao","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.scr.2021.102323_b0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1073\/pnas.90.2.532","article-title":"A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant","volume":"90","author":"Epstein","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.scr.2021.102323_b0020","doi-asserted-by":"crossref","first-page":"e2122","DOI":"10.1371\/journal.pone.0002122","article-title":"Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions","volume":"3","author":"Erceg","year":"2008","journal-title":"PLoS One."},{"issue":"4","key":"10.1016\/j.scr.2021.102323_b0025","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1046\/j.1471-4159.1996.67041677.x","article-title":"Specific delay in the degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis is derived from cellular proteolytic dysfunction rather than structural alteration of subunit c","volume":"67","author":"Ezaki","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.scr.2021.102323_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2202-5-57","article-title":"Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis","volume":"5","author":"Fossale","year":"2004","journal-title":"BMC Neurosci."},{"issue":"11","key":"10.1016\/j.scr.2021.102323_b0035","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/humu.23860","article-title":"Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease","volume":"40","author":"Gardner","year":"2019","journal-title":"Hum. Mutat."},{"issue":"30","key":"10.1016\/j.scr.2021.102323_b0040","doi-asserted-by":"crossref","first-page":"31058","DOI":"10.1074\/jbc.M400700200","article-title":"Maturation of human tripeptidyl-peptidase I in vitro","volume":"279","author":"Golabek","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.scr.2021.102323_b0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s100480050032","article-title":"Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis","volume":"1","author":"Haines","year":"1998","journal-title":"Neurogenetics."},{"issue":"4","key":"10.1016\/j.scr.2021.102323_b0050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta."},{"issue":"1-2","key":"10.1016\/j.scr.2021.102323_b0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0301-2115(98)00333-9","article-title":"A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis","volume":"281","author":"Junaid","year":"1999","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.scr.2021.102323_b0060","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"issue":"7","key":"10.1016\/j.scr.2021.102323_b0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.braindev.2008.12.008","article-title":"Towards understanding the neuronal ceroid lipofuscinoses","volume":"31","author":"Kohlsch\u00fctter","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.scr.2021.102323_b0070","first-page":"89","article-title":"What are the requirements for lysosomal degradation of subunit c of mitochondrial ATPase?","volume":"54","author":"Kominami","year":"2002","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.scr.2021.102323_b0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/humu.20400","article-title":"Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing","volume":"28","author":"Krawczak","year":"2007","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.scr.2021.102323_b0080","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1074\/jbc.M008562200","article-title":"The human CLN2 protein\/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH","volume":"276","author":"Lin","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.scr.2021.102323_b0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tice.2015.07.006","article-title":"A simple method for differentiation of H9 cells into neuroectoderm","volume":"47","author":"Liu","year":"2015","journal-title":"Tissue Cell."},{"issue":"2","key":"10.1016\/j.scr.2021.102323_b0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/geno.1998.5328","article-title":"Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis","volume":"50","author":"Liu","year":"1998","journal-title":"Genomics."},{"issue":"580","key":"10.1016\/j.scr.2021.102323_b0095","doi-asserted-by":"crossref","first-page":"eaaw0682","DOI":"10.1126\/scitranslmed.aaw0682","article-title":"Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies","volume":"13","author":"Lizarraga","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.scr.2021.102323_b0100","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/hmg\/ddt596","article-title":"Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway","volume":"23","author":"Lojewski","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2021.102323_b0105","doi-asserted-by":"crossref","first-page":"17504","DOI":"10.1038\/s41598-017-17882-1","article-title":"Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential","volume":"7","author":"Marei","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.scr.2021.102323_b0110","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ymgme.2017.12.255","article-title":"Molecular basis of CLN2 disease: A review and classification of TPP1 gene variants reported worldwide","volume":"123","author":"Mole","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.scr.2021.102323_b0115","unstructured":"Mole, S.E., Williams, R.E., 2001 [updated 2013]. Neuronal Ceroid-Lipofuscinoses, in: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya (Eds.) GeneReviews((R)). University of Washington, Seattle, Seattle, WA."},{"issue":"6","key":"10.1016\/j.scr.2021.102323_b0120","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1074\/jbc.M806947200","article-title":"Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis","volume":"284","author":"Pal","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.scr.2021.102323_b0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ajmg.1320420428","article-title":"Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)","volume":"42","author":"Palmer","year":"1992","journal-title":"Am. J. Med. Genet."},{"issue":"10","key":"10.1016\/j.scr.2021.102323_b0130","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1016\/S0021-9258(18)83610-9","article-title":"Ovine ceroid lipofuscinosis. The major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence","volume":"264","author":"Palmer","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.scr.2021.102323_b0135","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.7.e88","article-title":"Transcript analysis of the cystic fibrosis splicing mutation 1525\u20131G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers","volume":"40","author":"Ramalho","year":"2003","journal-title":"J. Med. Genet."},{"issue":"11","key":"10.1016\/j.scr.2021.102323_b0140","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.scr.2021.102323_b0145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/hmg\/6.4.591","article-title":"Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23","volume":"6","author":"Sharp","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.scr.2021.102323_b0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-018-0798-2","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1\/PPT1) and late infantile (CLN2\/TPP1) neuronal ceroid lipofuscinoses","volume":"13","author":"Sima","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.scr.2021.102323_b0155","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.scr.2021.102323_b0160","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/302427","article-title":"Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder","volume":"64","author":"Sleat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.scr.2021.102323_b0165","doi-asserted-by":"crossref","first-page":"e20121","DOI":"10.1371\/journal.pone.0020121","article-title":"A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement","volume":"6","author":"Symoens","year":"2011","journal-title":"PLoS One."},{"issue":"9","key":"10.1016\/j.scr.2021.102323_b0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0968-0004(99)01435-8","article-title":"Tripeptidyl peptidases: enzymes that count","volume":"24","author":"Tomkinson","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.scr.2021.102323_b0175","unstructured":"UCL, 2020. NCL Disease Mutation and Patient Database. University College London, London, United Kingdom. https:\/\/www.ucl.ac.uk\/ncl-disease\/mutation-and-patient-database (accessed on September 23, 2020)."},{"key":"10.1016\/j.scr.2021.102323_b0180","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.2649","article-title":"The pathobiology of splicing","volume":"220","author":"Ward","year":"2010","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.scr.2021.102323_b0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/humu.20493","article-title":"Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption","volume":"28","author":"Wimmer","year":"2007","journal-title":"Hum. Mutat."},{"issue":"13","key":"10.1016\/j.scr.2021.102323_b0190","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1074\/jbc.M313173200","article-title":"N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I","volume":"279","author":"Wujek","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.scr.2021.102323_b0195","doi-asserted-by":"crossref","unstructured":"Xu, M., Ouyang, Q., Gong, J., Pescosolido, M.F., Pruett, B.S., Mishra, S., Schmidt, M., Jones, R.N., Gamsiz Uzun, E.D., Lizarraga, S.B., Morrow, E.M., 2017. Mixed neurodevelopmental and neurodegenerative pathology in Nhe6-null mouse model of Christianson syndrome. eNeuro. 4, ENEURO.0388-0317.2017. doi:10.1523\/ENEURO.0388-17.2017.","DOI":"10.1523\/ENEURO.0388-17.2017"},{"key":"10.1016\/j.scr.2021.102323_b0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.conb.2015.10.006","article-title":"Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities","volume":"36","author":"Young-Pearse","year":"2016","journal-title":"Curr. Opin. Neurobiol."}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506121001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506121001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:35:40Z","timestamp":1761737740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506121001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"alternative-id":["S1873506121001690"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2021.102323","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.05.425495","asserted-by":"object"}]},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2021.102323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102323"}}